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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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Thanksgiving this year is going to be radically different for many
Americans, including my family.
I will celebrate my favorite holiday just with my wife Regina,
home in San Diego.
As it has for many Americans, the COVID-19 pandemic has
prevented us from hosting our usual small group of friends.
After eating a healthy brunch, we plan to have a Zoom call with
our HD-free “miracle” daughter Bianca, a junior history major at
the University of Pennsylvania. We are ever thankful that Bianca
did not have to face the devastating possibility of juvenile HD. We
will miss her, but are reassured knowing that she will spend the
day with her boyfriend and his immediate family in the East.
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We also hope to Zoom with some of our local friends.
However, despite the terrible pall cast by the pandemic over the
2020 holiday season, I feel extremely optimistic that researchers
will find a highly effective vaccine for the coronavirus.
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The announcements of preliminary data by Moderna and the team
of Pfizer and BioNTech revealed that their vaccine candidates
reduced COVID-19 infections by 95 percent in clinical trials.
Dr. Anthony Fauci, the director of the National Institutes of
Allergies and Infectious Diseases (NIAID), described the Moderna
data as “stunningly impressive,” noting that he would have settled
for 70-75 percent efficacy in a vaccine.
“It is really a spectacular result that I don’t think anybody had
anticipated would be this good,” Dr. Fauci said. He had similar
praise for the Pfizer/BioNTech data.
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Both of these trials use genetic approaches: they introduce the
virus’s own genes into cells to provoke an immune response.
According to the New York Times’ Coronavirus Vaccine Tracker,
several dozen other companies have embarked on clinical trial
programs using some form of approach based on genetics or other
cutting-edge strategies. Only ten projects are making vaccines
using the traditional approach of injecting weakened or dead
coronaviruses.
In all, scientists are testing 54 vaccines in clinical trials, and at
least 87 more are under investigation in animals.
Genetics-based approaches are familiar to the HD community,
where researchers have investigated the potential of gene silencing
drugs for more than a decade. Researchers in the lead program,
Roche’s historic GENERATION HD1 Phase 3 clinical trial, hope
to analyze data in 2022.
When I heard of the initial reports of Moderna’s genetics-based
approach, I felt deeply confident that humanity would ultimately
defeat the coronavirus.
The potentially record speed in getting a vaccine to the world is
testimony to the ingenuity, dedication, and focus of the biotech and
pharmaceutical industries, which I have observed with deep
interest in my nearly quarter century as an HD advocate and
student of the science – and as a writer summarizing the science in
simple terms.
In October, posting on Facebook an article on the bold Triplet
Therapeutics clinical trial program – yet another genetics-based
effort – I wrote the following: “Hail to the many imaginative and
hard-working companies in America’s pharmaceutical industry!”
I also salute the scientists involved, and the many pharmaceutical
and biotech firms of other nations engaged in the fight against
COVID-19 and HD.
Also, we must not forget the millions of doctors, nurses, and other
healthcare workers and first responders who have heroically
attempted to hold the line against COVID-19, thus giving the
researchers the time necessary to develop the vaccines.
Thanksgiving is our quintessential American holiday. This year,
with the pandemic, it takes on a global significance. Across all
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cultures and nations, the virus has led us to realize once again our
common humanity – and the collective efforts needed to safeguard
life for all.

Photo by Bianca Serbin, taken in fall 2009 at the San Diego
Botanic Garden (click here to read more).
Posted by Gene Veritas at 11:38 PM
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